Columbia Research Group, Inc.

Portland, Oregon 97239

0 studies enrolling now · 12 studies all time

What they study most

Chronic Kidney Disease (CKD), Clostridium Difficile Infection, Diabetes Mellitus, Type 2, Dyslipidemias, Gout, Healthy, Hyperlipidemia, Non-24-Hour Sleep-Wake Disorder, Pneumococcal Disease, Prophylaxis: Influenza, Smallpox

Studies at this site

• Clostridium Difficile Vaccine Efficacy Trial — Completed
• Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL — Paused
• A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment — Stopped early
• A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes Mellitus — Completed
• Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination — Completed
• Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects — Completed
• A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects — Completed
• Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events — Completed
• Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception — Completed
• Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder — Completed
• Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder — Completed
• A Clinical Study to Assess the Safety of a New Influenza Vaccine — Completed